Lexicon Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
11.13 |
16.07 |
14.13 |
35.38 |
97.89 |
173.26 |
| Przychód Δ r/r |
0.00% |
44.31% |
-12.03% |
150.34% |
176.68% |
77.00% |
| Przychód (min) |
5.59 |
6.57 |
6.58 |
11.49 |
31.78 |
56.25 |
| Przychód (max) |
26.91 |
35.26 |
31.17 |
94.33 |
260.99 |
461.96 |
| EBITDA (średnia) |
-11.13 |
-16.07 |
-14.13 |
-35.38 |
-97.89 |
-173.26 |
| EBIT (średnia) |
-11.13 |
-16.07 |
-14.13 |
-35.38 |
-97.89 |
-173.26 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-215.66 |
-101.61 |
-130.20 |
-59.21 |
-28.80 |
-35.20 |
| Zysk netto % |
-1937.26% |
-632.47% |
-921.26% |
-167.34% |
-29.42% |
-20.32% |
| EPS (średnia) |
-0.68 |
-0.32 |
-0.31 |
-0.21 |
-0.09 |
-0.11 |
| Liczba analityków (Przychody) |
5 |
4 |
5 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
4 |
4 |
4 |
3 |
1 |
1 |
| symbol |
LXRX |
LXRX |
LXRX |
LXRX |
LXRX |
LXRX |